Cassava Sciences, Inc. (SAVA) Covered Calls

You can sell covered calls on Cassava Sciences, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SAVA (prices last updated Fri 4:16 PM ET):

Cassava Sciences, Inc. (SAVA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
26.91 +0.77 27.25 27.50 2.8M - 1.3
Covered Calls For Cassava Sciences, Inc. (SAVA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 25 14.15 13.35 87.3% 885%
Jan 17 25 14.35 13.15 90.1% 514%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for nervous system disorders. Its lead therapeutic product candidate is PTI-125, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.